✦ LIBER ✦

Ezetimibe reduces low-density lipoprotein cholesterol: results of a phase III, randomized, double-blind, placebo-controlled trial

✍ Scribed by Knopp, R.H.; Gitter, H.; Truitt, T.; Lipka, L.J.; LeBeaut, A.P.; Suresh, R.; Veltri, E.P.

Book ID: 118630116
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 124 KB
Volume: 2
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(01)80027-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tanezumab Reduces Osteoarthritic Knee Pa

Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial

✍ Mark T. Brown; Frederick T. Murphy; David M. Radin; Isabelle Davignon; Michael D 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 467 KB

Effect of ezetimibe on low-density lipop

Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins

✍ H. Christian Geiss; Carsten Otto; Klaus G. Parhofer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Desmopressin orally disintegrating table

Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double-blind, placebo-controlled trial

✍ Jeffrey P. Weiss; Norman R. Zinner; Bjarke M. Klein; Jens Peter Nørgaard 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

Effect of gemfibrozil in men with primar

Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: A randomized, double-blind, placebo-controlled, crossover study

✍ Michael Miller; Paul S. Bachorik; Brian W. McCrindle; Peter O. Kwiterovich Jr. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 721 KB

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

(760): ALGRX 4975 reduces pain of interm

(760): ALGRX 4975 reduces pain of intermetatarsal neuroma: Preliminary results from a randomized, double-blind, placebo-controlled, phase II multicenter clinical trial

✍ E. Diamond; P. Richards; T. Miller 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB